跳转到主要内容


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
快速连接

左氧氟沙星(半水合物)

左氧氟沙星(半水合物) API

左氧氟沙星(半水合物)-API

CAS Number: 100986-85-4

治疗类别
抗感染
API技术
合成
剂型
口服固体制剂
注射剂
液体制剂
眼科用药
瑞迪博士研发状态
可得到
注册备案情况
USA
Europe
Korea
Saudi Arabia
Singapore
Russia
Malaysia
Turkey
Israel
Brazil
创新品牌(美国)
LEVAQUIN

作用机制

Levofloxacin inhibits bacterial type II topoisomerases, topoisomerase IV and DNA gyrase. Levofloxacin, like other fluoroquinolones, inhibits the A subunits of DNA gyrase, two subunits encoded by the gyrA gene. This results in strand breakage on a bacterial chromosome, supercoiling, and resealing; DNA replication and transcription is inhibited.

适应症

LEVAQUIN® is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with infections caused by designated, susceptible bacteria and in pediatric patients where indicated. 

  • Pneumonia: Nosocomial and Community Acquired 
  • Skin and Skin Structure Infections (SSSI): Complicated and Uncomplicated 
  • Chronic bacterial prostatitis
  • Inhalational Anthrax, Post-Exposure in adult and pediatric patients
  • Plague in adult and pediatric patients
  • Urinary Tract Infections (UTI): Complicated and Uncomplicated
  • Acute Pyelonephritis 
  • Acute Bacterial Exacerbation of Chronic Bronchitis
  • Acute Bacterial Sinusitis

Usage:

To reduce the development of drug-resistant bacteria and maintain the effectiveness of LEVAQUIN® and other antibacterial drugs, LEVAQUIN® should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria IQUIX® solution is a topical quinolone antimicrobial indicated for the treatment of corneal ulcer caused by susceptible strains of the following bacteria: 

  • Corynebacterium species* 
  • Staphylococcus aureus 
  • Staphylococcus epidermidis 
  • Streptococcus pneumonia 
  • Viridans group streptococci* 
  • Pseudomonas aeruginosa 
  • Serratia marcescens*

Dr. Reddy's的专长

Dr. Reddy's总部位于印度海得拉巴,是全球领先的活性药物成分(API)供应商之一。 Dr. Reddy's的API业务是美国、欧洲、巴西、拉丁美洲、日本、中国、韩国和新兴市场的制药公司的首选合作伙伴。

Dr. Reddy's博士的API业务在过去30多年来在开发和制造复杂API(如类固醇,多肽,复杂长链分子和高效API(HPAPI /肿瘤药物))方面所建立的深厚技术优势中茁壮成长。 我们在知识产权和法规事务方面的实力可以帮助我们始终如一地达到并超越监管标准,从而为这一专业知识提供补充。 Dr. Reddy's博士 左氧氟沙星(半水合物) API是研发,知识产权和监管方面广泛专业知识的结果。

帮助我们的客户率先进入市场的关键组成部分是响应式供应链。 我们通过确保所有设施都高效运行并达到最新的质量,安全和生产率标准来实现这一目标。 业务和工厂之间的强大互联可以快速响应动态的市场变化,从而避免短缺并满足需求的突然激增。

联系我们

请填写以下表格,我们会尽快与您联系

给我们发电子邮件: api@drreddys.com | +91 40 49002222

如果您有任何特定于国家的要求,我们将为您提供帮助。

免责声明

本目錄中的任何信息(包括對任何產品或服務的任何引用)均不構成銷售要約,或被解釋為代表銷售要約。受有效專利保護的產品不提供或供應用於商業用途。但是,只要存在此類監管豁免,就可以出於監管提交的目的提供此類產品的研究數量。買方應對各自市場的專利方案進行獨立評估,並承擔所有與專利相關的責任。在印度受有效專利保護的產品不可用於商業用途,但可用於第 107A 節。

FAQs

Levofloxacin belongs to the class of medicines known as quinolone antibiotics. It is a third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity.

Treatment of Acute Bacterial Sinusitis and Acute Exacerbation of Chronic Bronchitis when these infections have been adequately diagnosed.

Pneumonia - 500 mg orally or IV every 24 hours for 7 to 14 days. Prostatitis- 500 mg orally or IV every 24 hours for 28 days.

We offer Crystalline Form

Meet with our product experts in one-on-one virtual sessions at https://api.drreddys.com/meet-api-experts or Write to us at api@drreddys.com.